APO Research
Talk to an analyst

APO RESEARCH · REPORT

Anti-counterfeiting Pharmaceutical Packaging

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Anti-counterfeiting Pharmaceutical Packaging Market Outlook and Growth Opportunities 2026

26 December 2025196 pages

Choose your research edition.

Industry ResearchAnti-counterfeiting Pharmaceutical Packaging Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Anti-counterfeiting Pharmaceutical Packaging Industry Growth and Trends Forecast to 203293 pages · $3,450 USDMarket StructureGlobal Anti-counterfeiting Pharmaceutical Packaging Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032187 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Anti-counterfeiting Pharmaceutical Packaging Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Anti-counterfeiting Pharmaceutical Packaging Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Anti-counterfeiting Pharmaceutical Packaging market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Anti-counterfeiting Pharmaceutical Packaging is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Anti-counterfeiting Pharmaceutical Packaging is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Anti-counterfeiting Pharmaceutical Packaging is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Anti-counterfeiting Pharmaceutical Packaging market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Anti-counterfeiting Pharmaceutical Packaging market include Amcor PIc, Ball Corp., Becton Dickinson and Co., Berry Global Group Inc., Catalent Inc., Gerresheimer AG, O-I Glass Inc.SCHOTTAG, West Pharmaceutical Services Inc. and WestRock Co., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Anti-counterfeiting Pharmaceutical Packaging market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Anti-counterfeiting Pharmaceutical Packaging and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Anti-counterfeiting Pharmaceutical Packaging sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Anti-counterfeiting Pharmaceutical Packaging market size, projected growth trends, production technologies, key applications, and end-use industries.

Anti-counterfeiting Pharmaceutical Packaging Segment by Company

Amcor PIc

Ball Corp.

Becton Dickinson and Co.

Berry Global Group Inc.

Catalent Inc.

Gerresheimer AG

O-I Glass Inc.SCHOTTAG

West Pharmaceutical Services Inc.

WestRock Co.

Anti-counterfeiting Pharmaceutical Packaging Segment by Type

Plastic Film

Aluminum Foil

Glass

Anti-counterfeiting Pharmaceutical Packaging Segment by Application

Medicine

Nutraceuticals

Others

Anti-counterfeiting Pharmaceutical Packaging Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Anti-counterfeiting Pharmaceutical Packaging status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Anti-counterfeiting Pharmaceutical Packaging market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Anti-counterfeiting Pharmaceutical Packaging significant trends, drivers, influence factors in global and regions.

6. To analyze Anti-counterfeiting Pharmaceutical Packaging competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Anti-counterfeiting Pharmaceutical Packaging market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Anti-counterfeiting Pharmaceutical Packaging and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Anti-counterfeiting Pharmaceutical Packaging.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Anti-counterfeiting Pharmaceutical Packaging market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Anti-counterfeiting Pharmaceutical Packaging industry.

Chapter 3: Detailed analysis of Anti-counterfeiting Pharmaceutical Packaging manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Anti-counterfeiting Pharmaceutical Packaging in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Anti-counterfeiting Pharmaceutical Packaging in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Anti-counterfeiting Pharmaceutical Packaging Industry Trends Table 2. Anti-counterfeiting Pharmaceutical Packaging Industry Drivers Table 3. Anti-counterfeiting Pharmaceutical Packaging Industry Opportunities and Challenges Table 4. Anti-counterfeiting Pharmaceutical Packaging Industry Restraints Table 5. Global Anti-counterfeiting Pharmaceutical Packaging Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Anti-counterfeiting Pharmaceutical Packaging Revenue Share by Company (2021-2026) Table 7. Global Anti-counterfeiting Pharmaceutical Packaging Sales Volume by Company (k units) & (2021-2026) Table 8. Global Anti-counterfeiting Pharmaceutical Packaging Sales Volume Share by Company (2021-2026) Table 9. Global Anti-counterfeiting Pharmaceutical Packaging Average Price (USD/unit) of Company (2021-2026) Table 10. Global Anti-counterfeiting Pharmaceutical Packaging Company Ranking, (2024-2026) & (USD Million) Table 11. Global Anti-counterfeiting Pharmaceutical Packaging Key Company Manufacturing Base & Headquarters Table 12. Global Anti-counterfeiting Pharmaceutical Packaging Company, Product Type & Application Table 13. Global Anti-counterfeiting Pharmaceutical Packaging Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Anti-counterfeiting Pharmaceutical Packaging by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Plastic Film Table 18. Significant Companies of Aluminum Foil Table 19. Significant Companies of Glass Table 20. Global Anti-counterfeiting Pharmaceutical Packaging Sales Volume by Type 2021 VS 2025 VS 2032 (k units) Table 21. Global Anti-counterfeiting Pharmaceutical Packaging Sales Volume by Type (2021-2026) & (k units) Table 22. Global Anti-counterfeiting Pharmaceutical Packaging Sales Volume by Type (2027-2032) & (k units) Table 23. Global Anti-counterfeiting Pharmaceutical Packaging Sales Volume Share by Type (2021-2026) Table 24. Global Anti-counterfeiting Pharmaceutical Packaging Sales Volume Share by Type (2027-2032) Table 25. Global Anti-counterfeiting Pharmaceutical Packaging Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Anti-counterfeiting Pharmaceutical Packaging Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Anti-counterfeiting Pharmaceutical Packaging Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Anti-counterfeiting Pharmaceutical Packaging Sales Value Share by Type (2021-2026) Table 29. Global Anti-counterfeiting Pharmaceutical Packaging Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Medicine Table 31. Significant Companies of Nutraceuticals Table 32. Significant Companies of Others Table 33. Global Anti-counterfeiting Pharmaceutical Packaging Sales Volume by Application 2021 VS 2025 VS 2032 (k units) Table 34. Global Anti-counterfeiting Pharmaceutical Packaging Sales Volume by Application (2021-2026) & (k units) Table 35. Global Anti-counterfeiting Pharmaceutical Packaging Sales Volume by Application (2027-2032) & (k units) Table 36. Global Anti-counterfeiting Pharmaceutical Packaging Sales Volume Share by Application (2021-2026) Table 37. Global Anti-counterfeiting Pharmaceutical Packaging Sales Volume Share by Application (2027-2032) Table 38. Global Anti-counterfeiting Pharmaceutical Packaging Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Anti-counterfeiting Pharmaceutical Packaging Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global Anti-counterfeiting Pharmaceutical Packaging Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global Anti-counterfeiting Pharmaceutical Packaging Sales Value Share by Application (2021-2026) Table 42. Global Anti-counterfeiting Pharmaceutical Packaging Sales Value Share by Application (2027-2032) Table 43. Global Anti-counterfeiting Pharmaceutical Packaging Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 44. Global Anti-counterfeiting Pharmaceutical Packaging Sales by Region (2021-2026) & (k units) Table 45. Global Anti-counterfeiting Pharmaceutical Packaging Sales Market Share by Region (2021-2026) Table 46. Global Anti-counterfeiting Pharmaceutical Packaging Sales by Region (2027-2032) & (k units) Table 47. Global Anti-counterfeiting Pharmaceutical Packaging Sales Market Share by Region (2027-2032) Table 48. Global Anti-counterfeiting Pharmaceutical Packaging Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Anti-counterfeiting Pharmaceutical Packaging Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global Anti-counterfeiting Pharmaceutical Packaging Sales Value Share by Region (2021-2026) Table 51. Global Anti-counterfeiting Pharmaceutical Packaging Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global Anti-counterfeiting Pharmaceutical Packaging Sales Value Share by Region (2027-2032) Table 53. Global Anti-counterfeiting Pharmaceutical Packaging Market Average Price (USD/unit) by Region (2021-2026) Table 54. Global Anti-counterfeiting Pharmaceutical Packaging Market Average Price (USD/unit) by Region (2027-2032) Table 55. Global Anti-counterfeiting Pharmaceutical Packaging Sales by Country: 2021 VS 2025 VS 2032 (k units) Table 56. Global Anti-counterfeiting Pharmaceutical Packaging Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global Anti-counterfeiting Pharmaceutical Packaging Sales by Country (2021-2026) & (k units) Table 58. Global Anti-counterfeiting Pharmaceutical Packaging Sales Market Share by Country (2021-2026) Table 59. Global Anti-counterfeiting Pharmaceutical Packaging Sales by Country (2027-2032) & (k units) Table 60. Global Anti-counterfeiting Pharmaceutical Packaging Sales Market Share by Country (2027-2032) Table 61. Global Anti-counterfeiting Pharmaceutical Packaging Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global Anti-counterfeiting Pharmaceutical Packaging Sales Value Market Share by Country (2021-2026) Table 63. Global Anti-counterfeiting Pharmaceutical Packaging Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global Anti-counterfeiting Pharmaceutical Packaging Sales Value Market Share by Country (2027-2032) Table 65. Amcor PIc Company Information Table 66. Amcor PIc Business Overview Table 67. Amcor PIc Anti-counterfeiting Pharmaceutical Packaging Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 68. Amcor PIc Anti-counterfeiting Pharmaceutical Packaging Product Portfolio Table 69. Amcor PIc Recent Development Table 70. Ball Corp. Company Information Table 71. Ball Corp. Business Overview Table 72. Ball Corp. Anti-counterfeiting Pharmaceutical Packaging Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 73. Ball Corp. Anti-counterfeiting Pharmaceutical Packaging Product Portfolio Table 74. Ball Corp. Recent Development Table 75. Becton Dickinson and Co. Company Information Table 76. Becton Dickinson and Co. Business Overview Table 77. Becton Dickinson and Co. Anti-counterfeiting Pharmaceutical Packaging Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 78. Becton Dickinson and Co. Anti-counterfeiting Pharmaceutical Packaging Product Portfolio Table 79. Becton Dickinson and Co. Recent Development Table 80. Berry Global Group Inc. Company Information Table 81. Berry Global Group Inc. Business Overview Table 82. Berry Global Group Inc. Anti-counterfeiting Pharmaceutical Packaging Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 83. Berry Global Group Inc. Anti-counterfeiting Pharmaceutical Packaging Product Portfolio Table 84. Berry Global Group Inc. Recent Development Table 85. Catalent Inc. Company Information Table 86. Catalent Inc. Business Overview Table 87. Catalent Inc. Anti-counterfeiting Pharmaceutical Packaging Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 88. Catalent Inc. Anti-counterfeiting Pharmaceutical Packaging Product Portfolio Table 89. Catalent Inc. Recent Development Table 90. Gerresheimer AG Company Information Table 91. Gerresheimer AG Business Overview Table 92. Gerresheimer AG Anti-counterfeiting Pharmaceutical Packaging Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 93. Gerresheimer AG Anti-counterfeiting Pharmaceutical Packaging Product Portfolio Table 94. Gerresheimer AG Recent Development Table 95. O-I Glass Inc.SCHOTTAG Company Information Table 96. O-I Glass Inc.SCHOTTAG Business Overview Table 97. O-I Glass Inc.SCHOTTAG Anti-counterfeiting Pharmaceutical Packaging Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 98. O-I Glass Inc.SCHOTTAG Anti-counterfeiting Pharmaceutical Packaging Product Portfolio Table 99. O-I Glass Inc.SCHOTTAG Recent Development Table 100. West Pharmaceutical Services Inc. Company Information Table 101. West Pharmaceutical Services Inc. Business Overview Table 102. West Pharmaceutical Services Inc. Anti-counterfeiting Pharmaceutical Packaging Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 103. West Pharmaceutical Services Inc. Anti-counterfeiting Pharmaceutical Packaging Product Portfolio Table 104. West Pharmaceutical Services Inc. Recent Development Table 105. WestRock Co. Company Information Table 106. WestRock Co. Business Overview Table 107. WestRock Co. Anti-counterfeiting Pharmaceutical Packaging Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 108. WestRock Co. Anti-counterfeiting Pharmaceutical Packaging Product Portfolio Table 109. WestRock Co. Recent Development Table 110. Key Raw Materials Table 111. Raw Materials Key Suppliers Table 112. Anti-counterfeiting Pharmaceutical Packaging Distributors List Table 113. Anti-counterfeiting Pharmaceutical Packaging Customers List Table 114. Research Programs/Design for This Report Table 115. Authors List of This Report Table 116. Secondary Sources Table 117. Primary Sources List of Figures Figure 1. Anti-counterfeiting Pharmaceutical Packaging Product Image Figure 2. Global Anti-counterfeiting Pharmaceutical Packaging Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Anti-counterfeiting Pharmaceutical Packaging Sales Value (2021-2032) & (US$ Million) Figure 4. Global Anti-counterfeiting Pharmaceutical Packaging Sales (2021-2032) & (k units) Figure 5. Global Anti-counterfeiting Pharmaceutical Packaging Sales Average Price (USD/unit) & (2021-2032) Figure 6. Global Anti-counterfeiting Pharmaceutical Packaging Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Plastic Film Image Figure 10. Aluminum Foil Image Figure 11. Glass Image Figure 12. Global Anti-counterfeiting Pharmaceutical Packaging Sales Volume by Type (2021 VS 2025 VS 2032) & (k units) Figure 13. Global Anti-counterfeiting Pharmaceutical Packaging Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Anti-counterfeiting Pharmaceutical Packaging Sales Volume Share by Type (2021-2032) Figure 15. Global Anti-counterfeiting Pharmaceutical Packaging Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Anti-counterfeiting Pharmaceutical Packaging Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Anti-counterfeiting Pharmaceutical Packaging Sales Value Share by Type (2021-2032) Figure 18. Medicine Image Figure 19. Nutraceuticals Image Figure 20. Others Image Figure 21. Global Anti-counterfeiting Pharmaceutical Packaging Sales Volume by Application (2021 VS 2025 VS 2032) & (k units) Figure 22. Global Anti-counterfeiting Pharmaceutical Packaging Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global Anti-counterfeiting Pharmaceutical Packaging Sales Volume Share by Application (2021-2032) Figure 24. Global Anti-counterfeiting Pharmaceutical Packaging Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Anti-counterfeiting Pharmaceutical Packaging Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global Anti-counterfeiting Pharmaceutical Packaging Sales Value Share by Application (2021-2032) Figure 27. Global Anti-counterfeiting Pharmaceutical Packaging Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 28. Global Anti-counterfeiting Pharmaceutical Packaging Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global Anti-counterfeiting Pharmaceutical Packaging Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global Anti-counterfeiting Pharmaceutical Packaging Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America Anti-counterfeiting Pharmaceutical Packaging Sales Value (2021-2032) & (US$ Million) Figure 32. North America Anti-counterfeiting Pharmaceutical Packaging Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe Anti-counterfeiting Pharmaceutical Packaging Sales Value (2021-2032) & (US$ Million) Figure 34. Europe Anti-counterfeiting Pharmaceutical Packaging Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific Anti-counterfeiting Pharmaceutical Packaging Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Anti-counterfeiting Pharmaceutical Packaging Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America Anti-counterfeiting Pharmaceutical Packaging Sales Value (2021-2032) & (US$ Million) Figure 38. South America Anti-counterfeiting Pharmaceutical Packaging Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa Anti-counterfeiting Pharmaceutical Packaging Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa Anti-counterfeiting Pharmaceutical Packaging Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA Anti-counterfeiting Pharmaceutical Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA Anti-counterfeiting Pharmaceutical Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA Anti-counterfeiting Pharmaceutical Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada Anti-counterfeiting Pharmaceutical Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada Anti-counterfeiting Pharmaceutical Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada Anti-counterfeiting Pharmaceutical Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico Anti-counterfeiting Pharmaceutical Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico Anti-counterfeiting Pharmaceutical Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico Anti-counterfeiting Pharmaceutical Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany Anti-counterfeiting Pharmaceutical Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany Anti-counterfeiting Pharmaceutical Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany Anti-counterfeiting Pharmaceutical Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France Anti-counterfeiting Pharmaceutical Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France Anti-counterfeiting Pharmaceutical Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France Anti-counterfeiting Pharmaceutical Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. Anti-counterfeiting Pharmaceutical Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. Anti-counterfeiting Pharmaceutical Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. Anti-counterfeiting Pharmaceutical Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy Anti-counterfeiting Pharmaceutical Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy Anti-counterfeiting Pharmaceutical Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy Anti-counterfeiting Pharmaceutical Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain Anti-counterfeiting Pharmaceutical Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain Anti-counterfeiting Pharmaceutical Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain Anti-counterfeiting Pharmaceutical Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia Anti-counterfeiting Pharmaceutical Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia Anti-counterfeiting Pharmaceutical Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia Anti-counterfeiting Pharmaceutical Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands Anti-counterfeiting Pharmaceutical Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands Anti-counterfeiting Pharmaceutical Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands Anti-counterfeiting Pharmaceutical Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries Anti-counterfeiting Pharmaceutical Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries Anti-counterfeiting Pharmaceutical Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries Anti-counterfeiting Pharmaceutical Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China Anti-counterfeiting Pharmaceutical Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China Anti-counterfeiting Pharmaceutical Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China Anti-counterfeiting Pharmaceutical Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan Anti-counterfeiting Pharmaceutical Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan Anti-counterfeiting Pharmaceutical Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan Anti-counterfeiting Pharmaceutical Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea Anti-counterfeiting Pharmaceutical Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea Anti-counterfeiting Pharmaceutical Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea Anti-counterfeiting Pharmaceutical Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India Anti-counterfeiting Pharmaceutical Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India Anti-counterfeiting Pharmaceutical Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India Anti-counterfeiting Pharmaceutical Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia Anti-counterfeiting Pharmaceutical Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia Anti-counterfeiting Pharmaceutical Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia Anti-counterfeiting Pharmaceutical Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia Anti-counterfeiting Pharmaceutical Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia Anti-counterfeiting Pharmaceutical Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia Anti-counterfeiting Pharmaceutical Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil Anti-counterfeiting Pharmaceutical Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil Anti-counterfeiting Pharmaceutical Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil Anti-counterfeiting Pharmaceutical Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina Anti-counterfeiting Pharmaceutical Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina Anti-counterfeiting Pharmaceutical Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina Anti-counterfeiting Pharmaceutical Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile Anti-counterfeiting Pharmaceutical Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile Anti-counterfeiting Pharmaceutical Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile Anti-counterfeiting Pharmaceutical Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia Anti-counterfeiting Pharmaceutical Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia Anti-counterfeiting Pharmaceutical Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia Anti-counterfeiting Pharmaceutical Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru Anti-counterfeiting Pharmaceutical Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru Anti-counterfeiting Pharmaceutical Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru Anti-counterfeiting Pharmaceutical Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Anti-counterfeiting Pharmaceutical Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia Anti-counterfeiting Pharmaceutical Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Anti-counterfeiting Pharmaceutical Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel Anti-counterfeiting Pharmaceutical Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia Anti-counterfeiting Pharmaceutical Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia Anti-counterfeiting Pharmaceutical Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE Anti-counterfeiting Pharmaceutical Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE Anti-counterfeiting Pharmaceutical Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE Anti-counterfeiting Pharmaceutical Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey Anti-counterfeiting Pharmaceutical Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey Anti-counterfeiting Pharmaceutical Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey Anti-counterfeiting Pharmaceutical Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran Anti-counterfeiting Pharmaceutical Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran Anti-counterfeiting Pharmaceutical Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran Anti-counterfeiting Pharmaceutical Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt Anti-counterfeiting Pharmaceutical Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt Anti-counterfeiting Pharmaceutical Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt Anti-counterfeiting Pharmaceutical Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Anti-counterfeiting Pharmaceutical Packaging Value Chain Figure 126. Manufacturing Cost Structure Figure 127. Anti-counterfeiting Pharmaceutical Packaging Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • Plastic Film
  • Aluminum Foil
  • Glass
Applications
  • Medicine
  • Nutraceuticals
  • Others
Companies covered
  • Amcor PIc
  • Ball Corp.
  • Becton Dickinson and Co.
  • Berry Global Group Inc.
  • Catalent Inc.
  • Gerresheimer AG
  • O-I Glass Inc.SCHOTTAG
  • West Pharmaceutical Services Inc.
  • WestRock Co.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Anti-counterfeiting Pharmaceutical Packaging Sales Value (2021-2032)
  4. 1.2.2 Global Anti-counterfeiting Pharmaceutical Packaging Sales Volume (2021-2032)
  5. 1.2.3 Global Anti-counterfeiting Pharmaceutical Packaging Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Anti-counterfeiting Pharmaceutical Packaging Market Dynamics
  1. 2.1 Anti-counterfeiting Pharmaceutical Packaging Industry Trends
  2. 2.2 Anti-counterfeiting Pharmaceutical Packaging Industry Drivers
  3. 2.3 Anti-counterfeiting Pharmaceutical Packaging Industry Opportunities and Challenges
  4. 2.4 Anti-counterfeiting Pharmaceutical Packaging Industry Restraints
3 Anti-counterfeiting Pharmaceutical Packaging Market by Company
  1. 3.1 Global Anti-counterfeiting Pharmaceutical Packaging Company Revenue Ranking in 2025
  2. 3.2 Global Anti-counterfeiting Pharmaceutical Packaging Revenue by Company (2021-2026)
  3. 3.3 Global Anti-counterfeiting Pharmaceutical Packaging Sales Volume by Company (2021-2026)
  4. 3.4 Global Anti-counterfeiting Pharmaceutical Packaging Average Price by Company (2021-2026)
  5. 3.5 Global Anti-counterfeiting Pharmaceutical Packaging Company Ranking (2024-2026)
  6. 3.6 Global Anti-counterfeiting Pharmaceutical Packaging Company Manufacturing Base and Headquarters
  7. 3.7 Global Anti-counterfeiting Pharmaceutical Packaging Company Product Type and Application
  8. 3.8 Global Anti-counterfeiting Pharmaceutical Packaging Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Anti-counterfeiting Pharmaceutical Packaging Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Anti-counterfeiting Pharmaceutical Packaging Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Anti-counterfeiting Pharmaceutical Packaging Market by Type
  1. 4.1 Anti-counterfeiting Pharmaceutical Packaging Type Introduction
  2. 4.1.1 Plastic Film
  3. 4.1.2 Aluminum Foil
  4. 4.1.3 Glass
  5. 4.2 Global Anti-counterfeiting Pharmaceutical Packaging Sales Volume by Type
  6. 4.2.1 Global Anti-counterfeiting Pharmaceutical Packaging Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Anti-counterfeiting Pharmaceutical Packaging Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Anti-counterfeiting Pharmaceutical Packaging Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Anti-counterfeiting Pharmaceutical Packaging Sales Value by Type
  10. 4.3.1 Global Anti-counterfeiting Pharmaceutical Packaging Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Anti-counterfeiting Pharmaceutical Packaging Sales Value by Type (2021-2032)
  12. 4.3.3 Global Anti-counterfeiting Pharmaceutical Packaging Sales Value Share by Type (2021-2032)
5 Anti-counterfeiting Pharmaceutical Packaging Market by Application
  1. 5.1 Anti-counterfeiting Pharmaceutical Packaging Application Introduction
  2. 5.1.1 Medicine
  3. 5.1.2 Nutraceuticals
  4. 5.1.3 Others
  5. 5.2 Global Anti-counterfeiting Pharmaceutical Packaging Sales Volume by Application
  6. 5.2.1 Global Anti-counterfeiting Pharmaceutical Packaging Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Anti-counterfeiting Pharmaceutical Packaging Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Anti-counterfeiting Pharmaceutical Packaging Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Anti-counterfeiting Pharmaceutical Packaging Sales Value by Application
  10. 5.3.1 Global Anti-counterfeiting Pharmaceutical Packaging Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Anti-counterfeiting Pharmaceutical Packaging Sales Value by Application (2021-2032)
  12. 5.3.3 Global Anti-counterfeiting Pharmaceutical Packaging Sales Value Share by Application (2021-2032)
6 Anti-counterfeiting Pharmaceutical Packaging Regional Sales and Value Analysis
  1. 6.1 Global Anti-counterfeiting Pharmaceutical Packaging Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Anti-counterfeiting Pharmaceutical Packaging Sales by Region (2021-2032)
  3. 6.2.1 Global Anti-counterfeiting Pharmaceutical Packaging Sales by Region: 2021-2026
  4. 6.2.2 Global Anti-counterfeiting Pharmaceutical Packaging Sales by Region (2027-2032)
  5. 6.3 Global Anti-counterfeiting Pharmaceutical Packaging Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Anti-counterfeiting Pharmaceutical Packaging Sales Value by Region (2021-2032)
  7. 6.4.1 Global Anti-counterfeiting Pharmaceutical Packaging Sales Value by Region: 2021-2026
  8. 6.4.2 Global Anti-counterfeiting Pharmaceutical Packaging Sales Value by Region (2027-2032)
  9. 6.5 Global Anti-counterfeiting Pharmaceutical Packaging Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Anti-counterfeiting Pharmaceutical Packaging Sales Value (2021-2032)
  12. 6.6.2 North America Anti-counterfeiting Pharmaceutical Packaging Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Anti-counterfeiting Pharmaceutical Packaging Sales Value (2021-2032)
  15. 6.7.2 Europe Anti-counterfeiting Pharmaceutical Packaging Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Anti-counterfeiting Pharmaceutical Packaging Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Anti-counterfeiting Pharmaceutical Packaging Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Anti-counterfeiting Pharmaceutical Packaging Sales Value (2021-2032)
  21. 6.9.2 South America Anti-counterfeiting Pharmaceutical Packaging Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Anti-counterfeiting Pharmaceutical Packaging Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Anti-counterfeiting Pharmaceutical Packaging Sales Value Share by Country, 2025 VS 2032
7 Anti-counterfeiting Pharmaceutical Packaging Country-level Sales and Value Analysis
  1. 7.1 Global Anti-counterfeiting Pharmaceutical Packaging Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Anti-counterfeiting Pharmaceutical Packaging Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Anti-counterfeiting Pharmaceutical Packaging Sales by Country (2021-2032)
  4. 7.3.1 Global Anti-counterfeiting Pharmaceutical Packaging Sales by Country (2021-2026)
  5. 7.3.2 Global Anti-counterfeiting Pharmaceutical Packaging Sales by Country (2027-2032)
  6. 7.4 Global Anti-counterfeiting Pharmaceutical Packaging Sales Value by Country (2021-2032)
  7. 7.4.1 Global Anti-counterfeiting Pharmaceutical Packaging Sales Value by Country (2021-2026)
  8. 7.4.2 Global Anti-counterfeiting Pharmaceutical Packaging Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Anti-counterfeiting Pharmaceutical Packaging Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Anti-counterfeiting Pharmaceutical Packaging Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Anti-counterfeiting Pharmaceutical Packaging Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Anti-counterfeiting Pharmaceutical Packaging Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Anti-counterfeiting Pharmaceutical Packaging Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Anti-counterfeiting Pharmaceutical Packaging Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Anti-counterfeiting Pharmaceutical Packaging Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Anti-counterfeiting Pharmaceutical Packaging Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Anti-counterfeiting Pharmaceutical Packaging Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Anti-counterfeiting Pharmaceutical Packaging Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Anti-counterfeiting Pharmaceutical Packaging Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Anti-counterfeiting Pharmaceutical Packaging Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Anti-counterfeiting Pharmaceutical Packaging Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Anti-counterfeiting Pharmaceutical Packaging Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Anti-counterfeiting Pharmaceutical Packaging Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Anti-counterfeiting Pharmaceutical Packaging Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Anti-counterfeiting Pharmaceutical Packaging Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Anti-counterfeiting Pharmaceutical Packaging Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Anti-counterfeiting Pharmaceutical Packaging Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Anti-counterfeiting Pharmaceutical Packaging Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Anti-counterfeiting Pharmaceutical Packaging Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Anti-counterfeiting Pharmaceutical Packaging Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Anti-counterfeiting Pharmaceutical Packaging Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Anti-counterfeiting Pharmaceutical Packaging Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Anti-counterfeiting Pharmaceutical Packaging Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Anti-counterfeiting Pharmaceutical Packaging Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Anti-counterfeiting Pharmaceutical Packaging Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Anti-counterfeiting Pharmaceutical Packaging Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Anti-counterfeiting Pharmaceutical Packaging Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Anti-counterfeiting Pharmaceutical Packaging Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Anti-counterfeiting Pharmaceutical Packaging Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Anti-counterfeiting Pharmaceutical Packaging Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Anti-counterfeiting Pharmaceutical Packaging Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Anti-counterfeiting Pharmaceutical Packaging Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Anti-counterfeiting Pharmaceutical Packaging Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Anti-counterfeiting Pharmaceutical Packaging Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Anti-counterfeiting Pharmaceutical Packaging Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Anti-counterfeiting Pharmaceutical Packaging Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Anti-counterfeiting Pharmaceutical Packaging Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Anti-counterfeiting Pharmaceutical Packaging Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Anti-counterfeiting Pharmaceutical Packaging Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Anti-counterfeiting Pharmaceutical Packaging Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Anti-counterfeiting Pharmaceutical Packaging Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Anti-counterfeiting Pharmaceutical Packaging Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Anti-counterfeiting Pharmaceutical Packaging Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Anti-counterfeiting Pharmaceutical Packaging Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Anti-counterfeiting Pharmaceutical Packaging Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Anti-counterfeiting Pharmaceutical Packaging Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Anti-counterfeiting Pharmaceutical Packaging Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Anti-counterfeiting Pharmaceutical Packaging Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Anti-counterfeiting Pharmaceutical Packaging Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Anti-counterfeiting Pharmaceutical Packaging Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Anti-counterfeiting Pharmaceutical Packaging Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Anti-counterfeiting Pharmaceutical Packaging Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Anti-counterfeiting Pharmaceutical Packaging Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Anti-counterfeiting Pharmaceutical Packaging Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Anti-counterfeiting Pharmaceutical Packaging Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Anti-counterfeiting Pharmaceutical Packaging Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Anti-counterfeiting Pharmaceutical Packaging Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Anti-counterfeiting Pharmaceutical Packaging Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Anti-counterfeiting Pharmaceutical Packaging Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Anti-counterfeiting Pharmaceutical Packaging Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Anti-counterfeiting Pharmaceutical Packaging Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Anti-counterfeiting Pharmaceutical Packaging Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Anti-counterfeiting Pharmaceutical Packaging Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Anti-counterfeiting Pharmaceutical Packaging Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Anti-counterfeiting Pharmaceutical Packaging Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Anti-counterfeiting Pharmaceutical Packaging Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Anti-counterfeiting Pharmaceutical Packaging Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Anti-counterfeiting Pharmaceutical Packaging Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Anti-counterfeiting Pharmaceutical Packaging Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Anti-counterfeiting Pharmaceutical Packaging Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Anti-counterfeiting Pharmaceutical Packaging Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Anti-counterfeiting Pharmaceutical Packaging Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Anti-counterfeiting Pharmaceutical Packaging Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Anti-counterfeiting Pharmaceutical Packaging Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Anti-counterfeiting Pharmaceutical Packaging Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Anti-counterfeiting Pharmaceutical Packaging Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Anti-counterfeiting Pharmaceutical Packaging Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Anti-counterfeiting Pharmaceutical Packaging Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Anti-counterfeiting Pharmaceutical Packaging Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Anti-counterfeiting Pharmaceutical Packaging Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Anti-counterfeiting Pharmaceutical Packaging Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Anti-counterfeiting Pharmaceutical Packaging Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Amcor PIc
  2. 8.1.1 Amcor PIc Company Information
  3. 8.1.2 Amcor PIc Business Overview
  4. 8.1.3 Amcor PIc Anti-counterfeiting Pharmaceutical Packaging Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Amcor PIc Anti-counterfeiting Pharmaceutical Packaging Product Portfolio
  6. 8.1.5 Amcor PIc Recent Developments
  7. 8.2 Ball Corp.
  8. 8.2.1 Ball Corp. Company Information
  9. 8.2.2 Ball Corp. Business Overview
  10. 8.2.3 Ball Corp. Anti-counterfeiting Pharmaceutical Packaging Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Ball Corp. Anti-counterfeiting Pharmaceutical Packaging Product Portfolio
  12. 8.2.5 Ball Corp. Recent Developments
  13. 8.3 Becton Dickinson and Co.
  14. 8.3.1 Becton Dickinson and Co. Company Information
  15. 8.3.2 Becton Dickinson and Co. Business Overview
  16. 8.3.3 Becton Dickinson and Co. Anti-counterfeiting Pharmaceutical Packaging Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Becton Dickinson and Co. Anti-counterfeiting Pharmaceutical Packaging Product Portfolio
  18. 8.3.5 Becton Dickinson and Co. Recent Developments
  19. 8.4 Berry Global Group Inc.
  20. 8.4.1 Berry Global Group Inc. Company Information
  21. 8.4.2 Berry Global Group Inc. Business Overview
  22. 8.4.3 Berry Global Group Inc. Anti-counterfeiting Pharmaceutical Packaging Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Berry Global Group Inc. Anti-counterfeiting Pharmaceutical Packaging Product Portfolio
  24. 8.4.5 Berry Global Group Inc. Recent Developments
  25. 8.5 Catalent Inc.
  26. 8.5.1 Catalent Inc. Company Information
  27. 8.5.2 Catalent Inc. Business Overview
  28. 8.5.3 Catalent Inc. Anti-counterfeiting Pharmaceutical Packaging Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Catalent Inc. Anti-counterfeiting Pharmaceutical Packaging Product Portfolio
  30. 8.5.5 Catalent Inc. Recent Developments
  31. 8.6 Gerresheimer AG
  32. 8.6.1 Gerresheimer AG Company Information
  33. 8.6.2 Gerresheimer AG Business Overview
  34. 8.6.3 Gerresheimer AG Anti-counterfeiting Pharmaceutical Packaging Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Gerresheimer AG Anti-counterfeiting Pharmaceutical Packaging Product Portfolio
  36. 8.6.5 Gerresheimer AG Recent Developments
  37. 8.7 O-I Glass Inc.SCHOTTAG
  38. 8.7.1 O-I Glass Inc.SCHOTTAG Company Information
  39. 8.7.2 O-I Glass Inc.SCHOTTAG Business Overview
  40. 8.7.3 O-I Glass Inc.SCHOTTAG Anti-counterfeiting Pharmaceutical Packaging Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 O-I Glass Inc.SCHOTTAG Anti-counterfeiting Pharmaceutical Packaging Product Portfolio
  42. 8.7.5 O-I Glass Inc.SCHOTTAG Recent Developments
  43. 8.8 West Pharmaceutical Services Inc.
  44. 8.8.1 West Pharmaceutical Services Inc. Company Information
  45. 8.8.2 West Pharmaceutical Services Inc. Business Overview
  46. 8.8.3 West Pharmaceutical Services Inc. Anti-counterfeiting Pharmaceutical Packaging Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 West Pharmaceutical Services Inc. Anti-counterfeiting Pharmaceutical Packaging Product Portfolio
  48. 8.8.5 West Pharmaceutical Services Inc. Recent Developments
  49. 8.9 WestRock Co.
  50. 8.9.1 WestRock Co. Company Information
  51. 8.9.2 WestRock Co. Business Overview
  52. 8.9.3 WestRock Co. Anti-counterfeiting Pharmaceutical Packaging Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 WestRock Co. Anti-counterfeiting Pharmaceutical Packaging Product Portfolio
  54. 8.9.5 WestRock Co. Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Anti-counterfeiting Pharmaceutical Packaging Value Chain Analysis
  2. 9.1.1 Anti-counterfeiting Pharmaceutical Packaging Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Anti-counterfeiting Pharmaceutical Packaging Sales Mode & Process
  6. 9.2 Anti-counterfeiting Pharmaceutical Packaging Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Anti-counterfeiting Pharmaceutical Packaging Distributors
  9. 9.2.3 Anti-counterfeiting Pharmaceutical Packaging Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst